The Development of SGLT Inhibitors: From Phlorizin to Modern Therapeutics
Diabetes mellitus poses a significant and escalating burden on global public health. As a major breakthrough in glycemic control, sodium-glucose transporters (SGLT) inhibitors are now established as indispensable agents for managing type 2 diabetes. This status is evidenced by the continuously increasing market share i...